InflammoPharmacology

, Volume 11, Issue 1, pp 97–110 | Cite as

Treating inflammation: some (needless) difficulties for gaining acceptance of effective natural products and traditional medicines

  • D. E. Butters
  • M. W. Whitehouse
Article

Abstract

The quality of so-called 'natural medicines' is extraordinarily variable. Lack of resolute pharmacological assays contributes to this hiatus. More stringent evaluation of anti-inflammatory and anti-pyretic activities in rats can help resolve some of the uncertainties surrounding (a) preparations of some herbal products including so-called 'nature's aspirin' (e.g. willowbark, ginger), cat's claw, celery seed, etc., and (b) some animal lipids (e.g. Lyprinol® (NZ Mussel), emu and fish oils). These animal products can be a remarkable resource for supplementing conventional/allopathic therapy for inflammatory disease, e.g. providing lipoxygenase inhibitors. Beyond the verifiable science, the healing professions and the general public still need to examine more carefully criteria for QUALITY(S) in any alternative medicine—to ensure the good (= both reputations and products) are not destroyed by the bad—in essence counteracting Gresham's Law which states: the bad tends to displace the good.

QUALITY CONTROLS ASPIRIN-MIMICS EMU OIL MUSSEL LIPID LYPRINOL CELERY SEED 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. Altman, R. D. and Marcussen, K. C. (2001). Effects of a ginger extract on knee pain in patients with osteoarthritis, Arthritis Rheum. 44, 2531–2538.Google Scholar
  2. Amin, A. R., Vyas, P., Attur, M. et al. (1995). The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase, Proc. Natl. Acad. Sci. USA 92, 7926–7930.Google Scholar
  3. Bliddal, H., Rosetzky, A., Schlichting, P. et al. (2000). A randomized, placebo-centrolled, cross-over study of ginger extract and Ibuprofen in osteoarthritis, Osteoarthritis Cartilage 8, 9–12.Google Scholar
  4. Buchanan, W. W. and Kean, W. F. (2002). The treatment of acute rheumatism by salicin by T. J. Maclagan — The Lancet, 1876, J. Rheumatol. 29, 1321–1323.Google Scholar
  5. Caughey, D. E., Grigor, R. R., Caughey, E. R. et al. (1983). Perna canaliculus in the treatment of rheumatoid arthritis, Eur. J. Rheumatol. Inflamm. 6, 197–200.Google Scholar
  6. Desai, H. G., Kalro, R. H. and Choksi, A. P. (1990). Effect of ginger and garlic on DNA content of gastric aspirate, Ind. J. Med. Res. 92, 139–141.Google Scholar
  7. Duke, J. A. (2000). Forward to Mills and Bone. Principles and Practice of Phytotherapy: Modern Herbal Medicine, pp. viii–ix. Churchill Livingstone, Edinburgh.Google Scholar
  8. Ernst, E. and Chrubasik, S. (2000). Phyto-anti-inflammatories: a systemic review of randomised, placebo-control doubleblind trials, Rheum. Dis. Clin. N. Am. 26, 13–28.Google Scholar
  9. Ernst, E., ed., with Pittler, M. H., Stevinson, C., White, A. (Assoc. Eds) (2001). The Desktop Guide to Complementary and Alternative Medicines: an Evidence-Based Approach, 444 pp. Moseby, Edinburgh.Google Scholar
  10. Gibson, R. G. and Gibson, S. L. M. (1981). Green lipped mussel extract in arthritis, Lancet, 149.Google Scholar
  11. Gibson, S. L. M. and Gibson, R. G. (1998). Treatment of arthritis with a lipid extract of Perna canaliculus: a randomised trial, Compl. Ther. Med. 6, 122–126.Google Scholar
  12. Hung, D. Y., Mellick, G. D., Masci, P. P. et al. (1998). Focussed anti-thrombotic therapy: novel anti-platelet salicylates with reduced ulcerogenic potential and higher first pass detoxification than aspirin in rats, J. Lab. Clin. Med. 132, 469–277.Google Scholar
  13. Huskisson, E. C., Scott, J. and Bryans, R. (1981). Seatone is ineffective in rheumatoid arthritis, Br. Med. J. 262, 1358–1359.Google Scholar
  14. Jones, B. and Dixon, M. V. (1989). The Macmillan dictionary of biography, 3rd edn, p. 363. Macmillan, Melbourne.Google Scholar
  15. Koo, K. L. K., Ammit, A. J., Tran, V. H. et al. (2001). Gingerols and related analogues inhibit arachidonic acid-induced human platelet serotonin release and aggregation, Thromb. Res. 103, 387–397.Google Scholar
  16. Larkin, J. G., Capell, H. A. and Sturrock, R. D. (1985). Seatone in rheumatoid arthritis: a six-month placebo-controlledstudy, Ann. Rheum. Dis. 44, 199–201.Google Scholar
  17. Lipsey, R. G., Langley, P. C., Mahoney, D. M. (1985). Positive economics for Australian students, 2nd edn, pp. 679–680. Weidenfeld and Nicolson, London.Google Scholar
  18. Merck Index (2001). 13th edn, p. 871. Merck, Whitehouse Station, N.J.Google Scholar
  19. Mills, S. and Bone, K. (2000). Principles and Practice of Phytotherapy: Modern Herbal Medicine, pp. 139, 396–397. Churchill Livingstone, Edinburgh.Google Scholar
  20. Parke, D. V., Symons, A. M. and Parke, A. L. (1989). Oxyradicals, inflammation and drugs acting on oxyradical production, in: New Developments in Antirheumatic Therapy, K. D. Rainsford and G. P. Velo (Eds), pp. 187–206. Kluwer Academic Publishers, Dordrecht.Google Scholar
  21. Rainsford, K. D. (1984). Aspirin and the salicylates, pp. 1–12. Butterworths, London.Google Scholar
  22. Schwartz, J. I., Chan, C. C., Mukhopadhyay, S. et al. (1999). Cyclooxygenase-2 inhibition by rofecoxib reverses naturally occurring fever in humans, Clin. Pharmacol. Ther. 65, 653–660.Google Scholar
  23. Snowden, J. M. and Whitehouse, M. W. (1997). Anti-inflammatory activity of emu oils in rats, Inflammopharmacology 5, 127–132.Google Scholar
  24. Warner, T. D., Giuliano, F., Vojnovic, I. et al. (1999). Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis, Proc. Natl. Acad. Sci. USA 96, 7563–7568.Google Scholar
  25. Whitehouse, M. W. and Butters, D. E. (1999). Non-NSAID over-the counter (OTC) remedies for arthritis: good, bad or indifferent? Inflammopharmacology 7, 227–247.Google Scholar
  26. Whitehouse, M. W., Roberts, M. S. and Brooks, P. M. (1999). Over the counter (OTC) remedies for arthritis and rheumatism: how effective are they? Inflammopharmacology 7, 89–105.Google Scholar
  27. Wu, K. K., Sanduja, R., Tsai, A. et al. (1991). Aspirin inhibits interleukin 1-induced protaglandin H synthase expression in cultured endothelial cells, Proc. Natl. Acad. Sci. USA 88, 2384–2387.Google Scholar

Copyright information

© VSP 2003 2003

Authors and Affiliations

  • D. E. Butters
  • M. W. Whitehouse

There are no affiliations available

Personalised recommendations